These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 24332575)
1. Role of topoisomerase I and thymidylate synthase expression in sporadic colorectal cancer: associations with clinicopathological and molecular features. Azzoni C; Bottarelli L; Cecchini S; Ziccarelli A; Campanini N; Bordi C; Sarli L; Silini EM Pathol Res Pract; 2014 Feb; 210(2):111-7. PubMed ID: 24332575 [TBL] [Abstract][Full Text] [Related]
2. High thymidylate synthase expression is typical for sporadic MSI-H colorectal carcinoma. Okoń K; Klimkowska A; Wójcik P; Osuch C; Papla B; Stachura J Pol J Pathol; 2006; 57(1):29-33. PubMed ID: 16739880 [TBL] [Abstract][Full Text] [Related]
3. Thymidylate synthase, topoisomerase-1 and microsatellite instability: relationship with outcome in mucinous colorectal cancer treated with fluorouracil. Negri FV; Azzoni C; Bottarelli L; Campanini N; Mandolesi A; Wotherspoon A; Cunningham D; Scartozzi M; Cascinu S; Tinelli C; Silini EM; Ardizzoni A Anticancer Res; 2013 Oct; 33(10):4611-7. PubMed ID: 24123038 [TBL] [Abstract][Full Text] [Related]
4. Inter-relationship between microsatellite instability, thymidylate synthase expression, and p53 status in colorectal cancer: implications for chemoresistance. Popat S; Wort R; Houlston RS BMC Cancer; 2006 Jun; 6():150. PubMed ID: 16753067 [TBL] [Abstract][Full Text] [Related]
5. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Goel A; Nagasaka T; Arnold CN; Inoue T; Hamilton C; Niedzwiecki D; Compton C; Mayer RJ; Goldberg R; Bertagnolli MM; Boland CR Gastroenterology; 2007 Jan; 132(1):127-38. PubMed ID: 17087942 [TBL] [Abstract][Full Text] [Related]
6. Thymidylate synthase gene promoter polymorphisms are associated with TSmRNA expressions but not with microsatellite instability in colorectal cancer. Calascibetta A; Cabibi D; Martorana A; Sanguedolce G; Rausa L; Feo S; Dardanoni G; Sanguedolce R Anticancer Res; 2004; 24(6):3875-80. PubMed ID: 15736425 [TBL] [Abstract][Full Text] [Related]
7. RER and LOH association with sporadic colorectal cancer in Taiwanese patients. Tsai MH; Yang YC; Chen KH; Jiang JK; Chou SJ; Chiang TC; Jan HS; Lou MA Hepatogastroenterology; 2002; 49(45):672-7. PubMed ID: 12063967 [TBL] [Abstract][Full Text] [Related]
8. Associations between polymorphisms in the thymidylate synthase gene, the expression of thymidylate synthase mRNA and the microsatellite instability phenotype of colorectal cancer. Merkelbach-Bruse S; Hans V; Mathiak M; Sanguedolce R; Alessandro R; Rüschoff J; Büttner R; Houshdaran F; Gullotti L Oncol Rep; 2004 Apr; 11(4):839-43. PubMed ID: 15010882 [TBL] [Abstract][Full Text] [Related]
10. [Clinical significant of semiquantificating DNA topoisomerase- I mRNA in colorectal cancer]. Ishida H; Shirakawa K; Ohsawa T; Hayashi Y; Okada N; Nakada H; Yokoyama M Gan To Kagaku Ryoho; 2005 Sep; 32(9):1295-9. PubMed ID: 16184927 [TBL] [Abstract][Full Text] [Related]
11. Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy. Kostopoulos I; Karavasilis V; Karina M; Bobos M; Xiros N; Pentheroudakis G; Kafiri G; Papakostas P; Vrettou E; Fountzilas G BMC Cancer; 2009 Sep; 9():339. PubMed ID: 19775480 [TBL] [Abstract][Full Text] [Related]
12. [Prognostic value of thymidylate synthase, topoisomerase-1 and Ki-67 in advanced colorectal cancer patients on irinotecan and fluorouracil treatment]. Xu JM; Zhu BD; Mangia A; Simone G; Montemurro S; Giuliani F; Maiello E; Colucci G; Paradiso A Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):312-5. PubMed ID: 15996331 [TBL] [Abstract][Full Text] [Related]
13. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q. Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743 [TBL] [Abstract][Full Text] [Related]
14. CES2, ABCG2, TS and Topo-I primary and synchronous metastasis expression and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI regimen. Silvestris N; Simone G; Partipilo G; Scarpi E; Lorusso V; Brunetti AE; Maiello E; Paradiso A; Mangia A Int J Mol Sci; 2014 Sep; 15(9):15767-77. PubMed ID: 25198900 [TBL] [Abstract][Full Text] [Related]
15. Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases. Boonsong A; Curran S; McKay JA; Cassidy J; Murray GI; McLeod HL Hum Pathol; 2002 Nov; 33(11):1114-9. PubMed ID: 12454816 [TBL] [Abstract][Full Text] [Related]
16. Correlation between thymidylate synthase gene variants, RNA and protein levels in primary colorectal adenocarcinomas. Kristensen MH; Weidinger M; Bzorek M; Pedersen PL; Mejer J J Int Med Res; 2010; 38(2):484-97. PubMed ID: 20515563 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer. Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123 [TBL] [Abstract][Full Text] [Related]
18. [The significance and characteristics of chromosomal abnormalities in patients with microsatellite and chromosome stable colorectal carcinoma]. Xie D; Wu HX; Liu YD; Zeng SD; Lin F Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):11-5. PubMed ID: 17403304 [TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of the polymorphisms of thymidylate synthase on cell-free circulating DNA in blood of patients with advanced colorectal carcinoma. Schwarzenbach H; Goekkurt E; Pantel K; Aust DE; Stoehlmacher J Int J Cancer; 2010 Aug; 127(4):881-8. PubMed ID: 19998340 [TBL] [Abstract][Full Text] [Related]
20. Nuclear thymidylate synthase expression, p53 expression and 5FU response in colorectal carcinoma. Wong NA; Brett L; Stewart M; Leitch A; Longley DB; Dunlop MG; Johnston PG; Lessells AM; Jodrell DI Br J Cancer; 2001 Dec; 85(12):1937-43. PubMed ID: 11747337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]